Monoclonal antibody against chinese shrimp hemocyanin and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGHAI EPIZYME BIOMEDICAL TECHNOLOGY CO LTD
- Filing Date
- 2024-10-30
- Publication Date
- 2026-05-29
AI Technical Summary
In existing technologies, monoclonal antibodies against hemocyanin in Chinese shrimp are not expressed stably in hybridoma cells, making it difficult to effectively detect and monitor fluctuations in hemocyanin concentration.
The monoclonal antibody anti-SHC-5C8 against hemocyanin of Chinese shrimp was stably expressed in mammalian cells Expi293. It was expressed and purified in E. coli DH5α and Expi293 cells using the recombinant plasmid pcDNA3.1 to ensure the high specificity and stability of the antibody.
Stable expression and high-purity purification of monoclonal antibody against hemocyanin in Chinese shrimp were achieved in Expi293 cells. The antibody exhibits good specificity and can be used as a positive internal control for qualitative and quantitative detection of hemocyanin immune status.
Smart Images

Figure CN120349408B_ABST